Skip to main content
Glenmark to study efficacy of two antiviral drugs for treating Covid-19 - Hindustan Times 27-May-2020
Glenmark to study efficacy of two antiviral drugs for treating Covid-19 - Hindustan Times
Favipiravir is an oral antiviral drug approved in Japan since 2014 for treating novel or re-emerging influenza virus infections. Umifenovir is another oral antiviral drug licenced for the treatment and prophylaxis of influenza A and B infections in Russia and…
More...